193 related articles for article (PubMed ID: 37084848)
1. Autoantibodies against DNA topoisomerase I promote renal allograft rejection by increasing alloreactive T cell responses.
Gorbacheva V; Fan R; Miyairi S; Fairchild RL; Baldwin WM; Valujskikh A
Am J Transplant; 2023 Sep; 23(9):1307-1318. PubMed ID: 37084848
[TBL] [Abstract][Full Text] [Related]
2. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.
Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A
J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
[TBL] [Abstract][Full Text] [Related]
5. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
6. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
7. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection.
Sirak J; Orosz CG; Wakely E; VanBuskirk AM
Transplantation; 1997 May; 63(9):1300-7. PubMed ID: 9158025
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
10. Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.
Morris H; DeWolf S; Robins H; Sprangers B; LoCascio SA; Shonts BA; Kawai T; Wong W; Yang S; Zuber J; Shen Y; Sykes M
Sci Transl Med; 2015 Jan; 7(272):272ra10. PubMed ID: 25632034
[TBL] [Abstract][Full Text] [Related]
11. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
Ruiz P; Fuller J; Sanfilippo F
Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
[TBL] [Abstract][Full Text] [Related]
13. Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection.
Bharat A; Mohanakumar T
J Immunol Res; 2017; 2017():6312514. PubMed ID: 28164137
[TBL] [Abstract][Full Text] [Related]
14. Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia.
Gorbacheva V; Fan R; Beavers A; Fairchild RL; Baldwin WM; Valujskikh A
J Am Soc Nephrol; 2019 Dec; 30(12):2413-2425. PubMed ID: 31597715
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
16. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
17. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
[TBL] [Abstract][Full Text] [Related]
18. A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata.
Chandran SR; Mulley WR; Kanellis J; Nikolic-Paterson DJ; Ma FY
Exp Clin Transplant; 2018 Jun; 16(3):294-300. PubMed ID: 28760115
[TBL] [Abstract][Full Text] [Related]
19. ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.
Betjes MGH; Sablik KA; Litjens NHR; Otten HG; de Weerd AE
Hum Immunol; 2021 Feb; 82(2):89-96. PubMed ID: 33358038
[TBL] [Abstract][Full Text] [Related]
20. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3038. PubMed ID: 30728823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
